斯塔加特病:分子病原和当前治疗景观
Kunal Dayma1, Kalpana Rajanala2, Arun Upadhyay2
1Ocugen India, 5th Floor, AYDIV IT Park, Financial District, Nanakramguda, Hyderabad 500032, Telangana, India.
International journal of molecular sciences
|July 29, 2025
概括
星病 (STGD1) 涉及影响视力的遗传突变. 目前的研究正在探索各种疗法,包括基因和小分子治疗,以对抗视力丧失.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 斯塔格特病 (STGD1) 是一种与ABCA4基因相关的遗传性黄斑变性.
- 突变导致视网膜色素上皮层中有毒副产品的积累,导致视力丧失.
- 超过1200种ABCA4变种有助于STGD1的遗传复杂性和多样化的呈现.
研究的目的:
- 审查Stargardt病病理学和治疗策略的当前情况.
- 突出STGD的遗传异质性和表型变异性1.
- 讨论开发有效的STGD1治疗方法的挑战和未来方向.
主要方法:
- 对STGD1遗传学,病理学和正在进行的临床试验的文献综述.
- 对包括小分子,基因疗法和RORA基因疗法在内的试验性疗法的分析.
- 检查临床试验结果和挑战在基因型-表型相关性.
主要成果:
- STGD1的特征是ABCA4基因突变,导致脂素积累和视力受损.
- 目前正在研究许多治疗方法,针对不同的疾病机制.
- 临床试验有希望,但在优化疗效和理解遗传影响方面面临挑战.
结论:
- 有效的STGD1治疗需要解决遗传异质性和基因型-表型相关性.
- 未来的治疗可能会整合针对氧化应激,炎症和遗传修复的策略.
- 优化当前和新兴疗法的疗效仍然是斯塔格特病管理的关键目标.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
967
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
967
Gene Therapy
25.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.9K
Microorganisms in Medicine and Therapeutics
345
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
345
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Parkinson's Disease: Overview
710
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
710


